Illness	Number of cases
Malignant neoplasm of ovary (C56)	66
Malignant neoplasm of breast (C50.9)	63
Leiomyoma of uterus - Leiomyoma of uterus unspecified (D25.9)	51
Noninflammatory disorders of ovary fallopian tube and broad ligament (N83.2)	43
Malignant neoplasm of corpus uteri - Malignant neoplasm of endometrium (C54.1)	33
Other disorders of urinary system - Stress incontinence female male (N39.3)	20
Female genital prolapse (N81.1)	20
Benign neoplasm of ovary (D27)	19
Malignant neoplasm of cervix uteri - Malignant neoplasm of cervix uteri unspecified (C53.9)	17
Salpingitis and oophoritis (N70.0)	16

Top 10 treatments

Treatment	Number
Computer-assisted analysis of the images with 3D-analysis (3-990)	152
Computed tomography of the abdomen with contrast medium (3-225)	93
Surgical removal of a fallopian tube (5-661.62)	82
Other operations on the intestine (5-469.21)	61
Examination of the uterus by endoscopy (1-672)	57
Computed tomography of the chest with contrast medium (3-222)	53
Surgical removal or destruction of tissue in the abdominal cavity (5-543.42)	50
Surgical removal or destruction of tissue in the abdominal cavity (5-543.21)	41
Surgical opening of the abdominal cavity or tissue lying behind (retroperitoneum) (5-541.0)	39
Complete surgical removal of the uterus - hysterectomy (5-683.03)	39

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 2400

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

External quality assurance according to the DMP

Diabetes mellitus Typ 2

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ06
CQ27
CQ31

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
160	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
131	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
101	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Lectureships / teaching posts at colleges and universities
Student training (clinical traineeship / internship year)
Project-related cooperation with colleges and universities
Participation in multi-centre Phase I/II studies
Participation in multi-centre phase III/IV studies